^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Todai OncoPanel (TOP)

    Company:
    University of Tokyo Hospital
    Type:
    Other Approval

    Details

    Evidence
    News
    Todai OncoPanel is an oncogene panel test developed by laboratory of Professor Hiroyuki Mano, Graduate School of Medicine, The University of Tokyo. 467 gene mutations can be examined at one time in about two weeks.
    Cancer:
    Breast Cancer, Melanoma, Non Small Cell Lung Cancer
    Gene:
    ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2)
    Drug:
    Alecensa (alectinib), Gilotrif (afatinib), Herceptin (trastuzumab), Tafinlar (dabrafenib), Xalkori (crizotinib), Zelboraf (vemurafenib), Zykadia (ceritinib), erlotinib, gefitinib, lapatinib